Unknown

Dataset Information

0

O'Donnell-Luria-Rodan syndrome: description of a second multinational cohort and refinement of the phenotypic spectrum.


ABSTRACT:

Background

O'Donnell-Luria-Rodan syndrome (ODLURO) is an autosomal-dominant neurodevelopmental disorder caused by pathogenic, mostly truncating variants in KMT2E. It was first described by O'Donnell-Luria et al in 2019 in a cohort of 38 patients. Clinical features encompass macrocephaly, mild intellectual disability (ID), autism spectrum disorder (ASD) susceptibility and seizure susceptibility.

Methods

Affected individuals were ascertained at paediatric and genetic centres in various countries by diagnostic chromosome microarray or exome/genome sequencing. Patients were collected into a case cohort and were systematically phenotyped where possible.

Results

We report 18 additional patients from 17 families with genetically confirmed ODLURO. We identified 15 different heterozygous likely pathogenic or pathogenic sequence variants (14 novel) and two partial microdeletions of KMT2E. We confirm and refine the phenotypic spectrum of the KMT2E-related neurodevelopmental disorder, especially concerning cognitive development, with rather mild ID and macrocephaly with subtle facial features in most patients. We observe a high prevalence of ASD in our cohort (41%), while seizures are present in only two patients. We extend the phenotypic spectrum by sleep disturbances.

Conclusion

Our study, bringing the total of known patients with ODLURO to more than 60 within 2 years of the first publication, suggests an unexpectedly high relative frequency of this syndrome worldwide. It seems likely that ODLURO, although just recently described, is among the more common single-gene aetiologies of neurodevelopmental delay and ASD. We present the second systematic case series of patients with ODLURO, further refining the mutational and phenotypic spectrum of this not-so-rare syndrome.

SUBMITTER: Velmans C 

PROVIDER: S-EPMC10256139 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

O'Donnell-Luria-Rodan syndrome: description of a second multinational cohort and refinement of the phenotypic spectrum.

Velmans Clara C   O'Donnell-Luria Anne H AH   Argilli Emanuela E   Tran Mau-Them Frederic F   Vitobello Antonio A   Chan Marcus Cy MC   Fung Jasmine Lee-Fong JL   Rech Megan M   Abicht Angela A   Aubert Mucca Marion M   Carmichael Jason J   Chassaing Nicolas N   Clark Robin R   Coubes Christine C   Denommé-Pichon Anne-Sophie AS   de Dios John Karl JK   England Eleina E   Funalot Benoit B   Gerard Marion M   Joseph Maries M   Kennedy Colleen C   Kumps Camille C   Willems Marjolaine M   van de Laar Ingrid M B H IMBH   Aarts-Tesselaar Coranne C   van Slegtenhorst Marjon M   Lehalle Daphné D   Leppig Kathleen K   Lessmeier Lennart L   Pais Lynn S LS   Paterson Heather H   Ramanathan Subhadra S   Rodan Lance H LH   Superti-Furga Andrea A   Chung Brian H Y BHY   Sherr Elliott E   Netzer Christian C   Schaaf Christian P CP   Erger Florian F  

Journal of medical genetics 20210728 7


<h4>Background</h4>O'Donnell-Luria-Rodan syndrome (ODLURO) is an autosomal-dominant neurodevelopmental disorder caused by pathogenic, mostly truncating variants in <i>KMT2E</i>. It was first described by O'Donnell-Luria <i>et al</i> in 2019 in a cohort of 38 patients. Clinical features encompass macrocephaly, mild intellectual disability (ID), autism spectrum disorder (ASD) susceptibility and seizure susceptibility.<h4>Methods</h4>Affected individuals were ascertained at paediatric and genetic c  ...[more]

Similar Datasets

| S-EPMC9016787 | biostudies-literature
| S-EPMC7935518 | biostudies-literature
| S-EPMC9604141 | biostudies-literature
| S-EPMC8901719 | biostudies-literature
| S-EPMC6180513 | biostudies-literature
| S-EPMC6503218 | biostudies-literature
| S-EPMC4652067 | biostudies-literature
| S-EPMC6231716 | biostudies-literature
| S-EPMC10756722 | biostudies-literature